AIS Health

Scott Leslie, director of health outcomes, shares more about the study “Real-World Case Series Study of Spinal Muscular Atrophy Pediatric Patients Treated With Onasemnogene Abeparvovec (Zolgensma)”

A look at the specialty landscape and how Prime delivers value to employers

publications Learnings and impact generated from artificial intelligence (AI) systems February 18, 2025 Over time, technology has significantly contributed to health care advancements. Some of...

Get the specialty care you need We all need a little support. Someone who can answer questions, provide guidance and help navigate challenges. Our care specialists are here to help. Breadcrumb...

Managed Healthcare Executive

What works and what doesn’t

Formulary Watch: The new program, which begins in January 2025, provides members of Prime Therapeutics support for navigating utilization management requirements and finding financial assistance.